© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Mosapride Citrate stands as a selective 5-HT4 receptor agonist used widely in the pharmaceutical industry. Developed originally for gastrointestinal motility disorders, Mosapride Citrate helps improve the movement of food through the stomach and intestine. As someone who has spent hours reviewing clinical journals and examining samples in chemistry labs, I appreciate the value of precise physical information when working with this compound.
This compound presents as C21H25ClFN3O8, showing a clear structure of blended functional groups. Its molecular weight comes in at 517.88 g/mol, a figure every manufacturer and chemist keeps in mind for dosage calculation and process scaling. Mosapride Citrate features the chemical backbone of a substituted benzamide, fused with a piperidine ring and a quaternary ammonium group. The presence of both citric acid and Mosapride boosts its solubility in various polar solvents, a key property during formulation development. I’ve worked with batches of crystalline Mosapride Citrate where the purity and reactivity derive directly from this careful structure.
Mosapride Citrate appears typically as a white to off-white crystalline powder or fine flakes, free-flowing and easily handled with standard lab tools. Sometimes, in larger production settings, it arrives as solid pearls or granules, though the powder form dominates the market due to its quick dissolution and accurate measurement. Its density, sitting around 1.43 g/cm³, makes it manageable during transport and storage because it neither clumps heavily under normal humidity nor dusts excessively. From my own handling, consistency in the physical form reflects synthetic process integrity — poorly formed crystals often signal impurity risks.
Global trade relies on straightforward product classification, so Mosapride Citrate falls under the specific HS Code for pharmaceutical raw materials: 2933.19. Each shipment requires strict compliance with this code to clear customs and ensure traceability through supply chains. Working with customs documentation firsthand, one misstep in HS coding can delay entire production lines and expose companies to regulatory fines. Consistent documentation, including weight, form, and manufacturing origin, acts as a safeguard against these operational headaches.
Storage conditions play a big role in Mosapride Citrate’s longevity. Cool, dark, and dry spaces prevent degradation under heat or UV exposure. The compound dissolves well in water and ethanol, giving formulation labs flexibility to prepare both liquid solutions and solid dosage forms. Its solubility is enhanced by the citrate group, which translates to more predictable pharmacokinetics when administered to patients. Experience in the lab has shown that improper storage can prompt clumping or yellowing — clear visual warnings that product quality is slipping.
Any chemical synthesis lab must weigh the safety profile. Mosapride Citrate, while safer than many cytotoxic substances, demands gloves, goggles, and ventilation. The compound does not produce noxious fumes at room temperature, but ingestion, inhalation, or prolonged contact can be harmful. Safety Data Sheets list it as hazardous in concentrated form, with risks similar to other pharmaceutical intermediates, such as mild skin irritation or respiratory discomfort. Dropping vigilance on PPE or containment protocols invites unnecessary exposure, especially during weighing and mixing. Incidents often stem from rushed sampling or careless transfer — mistakes I’ve seen that are preventable by routine protocol adherence.
The pharmaceutical industry looks to Mosapride Citrate as a core raw material for making prokinetic agents that support digestive health. Solid, consistent supply chains depend entirely on clear, science-backed sourcing, accurate material identification, and robust storage. Raw Mosapride Citrate needs to pass strict quality and compliance checks before formulation or blending. End-use clients, from global pharma corporations to hospital suppliers, count on the robust characterization — molecular formula, melting point, specific gravity — to plan and execute their production without dangerous surprises.
Disruptions in supply can limit access for patients with digestive disorders. Shipping delays, improper labeling, and lapses in chemical purity all lead to bottlenecks. I’ve found that best practice comes from a solid partnership between suppliers and pharmaceutical manufacturers. Regular audits through the supply chain, transparent specification sheets, and strong in-country logistics support pave the way for uninterrupted access. Training warehouse and lab staff on safe short-term and long-term storage, along with simple spill management, helps protect both worker safety and product stability.
With an aging world population and growing rates of gastrointestinal illness, demand for safe, consistent prokinetic drugs — and therefore Mosapride Citrate — keeps rising. The importance of clear, evidence-based documentation and hazard management continues to grow, especially as regulators in different regions tighten scrutiny on pharmaceutical raw materials. Good communication between production, regulatory, and research teams helps keep the development process moving forward and preserves patient safety. Mosapride Citrate, with its well-characterized profile, stands out as an example of how precise chemical documentation and practical handling make all the difference from synthesis to the patient bedside.
